In-depth interviews of patients with primary immunodeficiency who have experienced pump and rapid push subcutaneous infusions of immunoglobulins reveal new insights on their preference and expectations

PURPOSE: Patients with primary immunodeficiency (PID) often receive immunoglobulin replacement therapy (IgRT). Physicians and patients have the choice between various methods of administration. For subcutaneous immunoglobulin infusions, patients may use an automated pump (P) or push the plunger of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozon, Grégoire Jacques Noël, Clerson, Pierre, Dokhan, Annaïk, Fardini, Yann, Sala, Taylor Pindi, Crave, Jean-Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875589/
https://www.ncbi.nlm.nih.gov/pubmed/29618922
http://dx.doi.org/10.2147/PPA.S156983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875589/
https://www.ncbi.nlm.nih.gov/pubmed/29618922
http://dx.doi.org/10.2147/PPA.S156983

Ejemplares similares